KRISTINA RISER: Open Payments
NPI 1083216071 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 20 payments from 11 companies in 2025. Trend: 2023 $754 · 2024 $874 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $146 |
| Lundbeck LLC | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 2 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Alkermes, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: ABILIFY MAINTENA, Qelbree, INGREZZA, COBENFY, LYBALVI, CAPLYTA, Auvelity, VRAYLAR.
Industry payments across TN — which companies pay providers there.
